Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kutzner, Heinz [VerfasserIn]   i
 Jutzi, Tanja [VerfasserIn]   i
 Krahl, Dieter [VerfasserIn]   i
 Krieghoff-Henning, Eva [VerfasserIn]   i
 Heppt, Markus V. [VerfasserIn]   i
 Hekler, Achim [VerfasserIn]   i
 Schmitt, Maximilian V. [VerfasserIn]   i
 Maron, Roman C. [VerfasserIn]   i
 Fröhling, Stefan [VerfasserIn]   i
 Kalle, Christof von [VerfasserIn]   i
 Brinker, Titus Josef [VerfasserIn]   i
Titel:Overdiagnosis of melanoma
Titelzusatz:causes, consequences and solutions
Verf.angabe:Heinz Kutzner, Tanja B. Jutzi, Dieter Krahl, Eva I. Krieghoff‐Henning, Markus V. Heppt, Achim Hekler, Max Schmitt, Roman C.R. Maron, Stefan Fröhling, Christof von Kalle, Titus J. Brinker
E-Jahr:2020
Jahr:25 August 2020
Umfang:8 S.
Fussnoten:Gesehen am 04.02.2021
Titel Quelle:Enthalten in: Deutsche Dermatologische GesellschaftJournal der Deutschen Dermatologischen Gesellschaft
Ort Quelle:Berlin : Wiley-Blackwell, 2003
Jahr Quelle:2020
Band/Heft Quelle:18(2020), 11, Seite 1236-1243
ISSN Quelle:1610-0387
Abstract:Malignant melanoma is the skin tumor that causes most deaths in Germany. At an early stage, melanoma is well treatable, so early detection is essential. However, the skin cancer screening program in Germany has been criticized because although melanomas have been diagnosed more frequently since introduction of the program, the mortality from malignant melanoma has not decreased. This indicates that the observed increase in melanoma diagnoses be due to overdiagnosis, i.e. to the detection of lesions that would never have created serious health problems for the patients. One of the reasons is the challenging distinction between some benign and malignant lesions. In addition, there may be lesions that are biologically equivocal, and other lesions that are classified as malignant according to current criteria, but that grow so slowly that they would never have posed a threat to patient’s life. So far, these “indolent” melanomas cannot be identified reliably due to a lack of biomarkers. Moreover, the likelihood that an in-situ melanoma will progress to an invasive tumor still cannot be determined with any certainty. When benign lesions are diagnosed as melanoma, the consequences are unnecessary psychological and physical stress for the affected patients and incurred therapy costs. Vice versa, underdiagnoses in the sense of overlooked melanomas can adversely affect patients’ prognoses and may necessitate more intense therapies. Novel diagnostic options could reduce the number of over- and underdiagnoses and contribute to more objective diagnoses in borderline cases. One strategy that has yielded promising results in pilot studies is the use of artificial intelligence-based diagnostic tools. However, these applications still await translation into clinical and pathological routine.
DOI:doi:10.1111/ddg.14233
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/https://doi.org/10.1111/ddg.14233
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.14233
 DOI: https://doi.org/10.1111/ddg.14233
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1747420875
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68688577   QR-Code
zum Seitenanfang